2024

1. Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer

   Clinical Lung Cancer, Vol. 25, Núm. 3, pp. 233-243.e8